NEUCA S.A. (WSE:NEU)
Poland · Delayed Price · Currency is PLN 790.00
-8.00 (-1.00%)
Nov 14, 2025, 5:00 PM CET
NEUCA Market Cap
NEUCA has a market cap or net worth of 3.54 billion as of November 14, 2025. Its market cap has decreased by -3.15% in one year.
Market Cap
3.54B
Enterprise Value
4.41B
Revenue
13.04B
Ranking
n/a
PE Ratio
26.55
Stock Price
790.00
Market Cap Chart
Since November 22, 2004, NEUCA's market cap has increased from 116.73M to 3.54B, an increase of 2,934.63%. That is a compound annual growth rate of 17.65%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 14, 2025 | 3.54B | -9.17% |
| Dec 30, 2024 | 3.90B | -4.37% |
| Dec 29, 2023 | 4.08B | 44.23% |
| Dec 30, 2022 | 2.83B | -23.49% |
| Dec 30, 2021 | 3.70B | 29.38% |
| Dec 30, 2020 | 2.86B | 79.60% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Diagnostyka | 6.10B |
| Synektik Spólka Akcyjna | 2.22B |
| Voxel | 1.63B |
| Celon Pharma | 1.15B |
| Selvita | 758.08M |
| Centrum Medyczne ENEL-MED | 523.19M |
| Bioceltix | 462.41M |
| Ryvu Therapeutics | 453.38M |